Orthofix Medical Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Orthofix Medical Inc. (OFIX) reported Share-based Payment Arrangement, Expense, Tax Benefit of $5.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-24
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2014-03-31 was $412.00K, a 26.82% decline year-over-year.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2013-12-31 was $0.00.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2013-09-30 was -$37.00K.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2013-06-30 was -$1.32M.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $5.50M, a 5.17% decline from fiscal 2024.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $5.80M, a 0.00% change from fiscal 2023.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $5.80M, a 75.76% increase from fiscal 2022.
- Orthofix Medical Inc. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $3.30M, a 6.45% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.50M 10-K · filed 2026-02-24 | |||||
| 2024-12-31 | $5.80M 10-K · filed 2026-02-24 | |||||
| 2023-12-31 | $5.80M 10-K · filed 2026-02-24 | |||||
| 2022-12-31 | $3.30M 10-K · filed 2025-02-25 | |||||
| 2021-12-31 | $3.10M 10-K · filed 2024-03-05 | |||||
| 2020-12-31 | $3.20M 10-K · filed 2023-03-06 | |||||
| 2019-12-31 | $3.50M 10-K · filed 2022-02-25 | |||||
| 2018-12-31 | $3.20M 10-K · filed 2021-02-26 | $3.80M 10-K · filed 2019-02-25 | ||||
| 2017-12-31 | $3.40M 10-K · filed 2020-02-24 | |||||
| 2016-12-31 | $4.30M 10-K · filed 2019-02-25 | |||||
| 2015-12-31 | $1.60M 10-K · filed 2018-02-26 | |||||
| 2014-12-31 | $1.30M 10-K · filed 2017-02-27 | |||||
| 2014-03-31 | $412.00K 10-Q · filed 2014-05-08 | $412.00K derived: sum of 2 quarters · filed 2014-05-08 | $375.00K derived: sum of 3 quarters · filed 2014-05-08 | -$946.00K derived: sum of 4 quarters · filed 2014-05-08 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$37.00K derived: sum of 2 quarters · filed 2014-03-31 | -$1.36M derived: sum of 3 quarters · filed 2014-03-31 | -$795.00K 10-K · filed 2014-03-31 | ||
| 2013-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | -$1.36M derived: sum of 2 quarters · filed 2014-03-25 | -$795.00K 10-Q · filed 2014-03-25 | |||
| 2013-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-03-24 | -$758.00K 10-Q · filed 2014-03-24 | ||||
| 2013-03-31 | $563.00K 10-Q · filed 2014-05-08 | |||||
| 2012-12-31 | -$2.91M 10-K · filed 2014-03-31 | |||||
| 2012-03-31 | -$389.00K 10-Q/A · filed 2014-03-24 | $1.01M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |